Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial

A Patient with Leiden V Mutation, Multiple Sclerosis, Psoriasis, and Sicca Syndrome: Could Celecoxib and Fingolimod Adversely Affect the Heart?

(2012) G. Cocco   Cardiovascular Toxicology

Systematic review of disease-modifying therapies to assess unmet needs in multiple sclerosis: tolerability and adherence

(2012) G Giovannoni et al.   Multiple Sclerosis Journal

The changing face of multiple sclerosis clinical trial populations

(2011) Bernard M.J. Uitdehaag et al.   CURRENT MEDICAL RESEARCH AND OPINION

Delayed fingolimod-associated asystole

(2011) Patricio S Espinosa et al.   Multiple Sclerosis Journal

Future clinical challenges in multiple sclerosis: Relevance to sphingosine 1-phosphate receptor modulator therapy

(2011) R. Hohlfeld et al.   NEUROLOGY

A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis

(2010) Ludwig Kappos et al.   NEW ENGLAND JOURNAL OF MEDICINE

Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis

(2010) Jeffrey A. Cohen et al.   NEW ENGLAND JOURNAL OF MEDICINE